CriteriaInfectious diseases

Severity and treatment of a first C. difficile infection episode (IDSA/SHEA)

Classifies a first Clostridioides difficile infection episode as non-severe, severe or fulminant and suggests treatment per the IDSA/SHEA guideline.

Updated 30 October 2026

When to use it

Adults with confirmed C. difficile infection in a first episode (not recurrences).

Warning

Adjust doses and choice to local availability, renal function and interactions; recurrences follow a different scheme.

What it needs

  • White blood cell countUnits: ×10⁹/L, /µL
  • Serum creatinineUnits: mg/dL, µmol/L
  • Signs of fulminant diseaseOptions: Hypotension or shock · Ileus · Megacolon

The points for each answer and the automatic total are in the app.

How to interpret it

Severity
ResultInterpretation
≤ 1Non-severe: fidaxomicin 200 mg every 12 h for 10 days (preferred) or oral vancomycin 125 mg every 6 h for 10 days
2Severe (WBC ≥ 15 × 10⁹/L or creatinine > 1.5 mg/dL): fidaxomicin 200 mg every 12 h or oral vancomycin 125 mg every 6 h, 10 days
≥ 3Fulminant: vancomycin 500 mg every 6 h orally or by tube + IV metronidazole 500 mg every 8 h; surgical review

Practical tip

Stop the inciting antibiotic if possible and avoid antiperistaltic agents in the acute phase.

2 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top